Edition:
United Kingdom

Avid Bioservices Inc (CDMO.OQ)

CDMO.OQ on NASDAQ Stock Exchange Capital Market

3.74USD
25 Apr 2018
Change (% chg)

-- (--)
Prev Close
$3.74
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
83,088
52-wk High
$5.77
52-wk Low
$2.25

Chart for

About

Avid Bioservices, Inc., formerly Peregrine Pharmaceuticals, Inc., is a biopharmaceutical company. The Company is engaged in providing contract manufacturing services for third party customers on a fee-for-service basis while also supporting its internal drug development efforts. The Company delivers pharmaceutical products... (more)

Overall

Beta: 2.16
Market Cap(Mil.): $211.65
Shares Outstanding(Mil.): 55.55
Dividend: --
Yield (%): --

Financials

  CDMO.OQ Industry Sector
P/E (TTM): -- 29.67 32.21
EPS (TTM): -0.55 -- --
ROI: -52.59 13.44 13.05
ROE: -69.19 15.16 14.90

BRIEF-Avid Bioservices Provides Update On Ongoing Expansion Of Process Development Capabilities And Laboratory Infrastructure

* AVID BIOSERVICES PROVIDES UPDATE ON ONGOING EXPANSION OF PROCESS DEVELOPMENT CAPABILITIES AND LABORATORY INFRASTRUCTURE

24 Apr 2018

BRIEF-Avid Bioservices Selected By Acumen Pharmaceuticals To Lead Process Development And Clinical Manufacture Of Novel Alzheimer's Disease Candidate

* AVID BIOSERVICES SELECTED BY ACUMEN PHARMACEUTICALS TO LEAD PROCESS DEVELOPMENT AND CLINICAL MANUFACTURE OF NOVEL ALZHEIMER’S DISEASE CANDIDATE

01 Mar 2018

BRIEF-Avid Bioservices Announces Proposed Offering Of Common Stock

* AVID BIOSERVICES ANNOUNCES PROPOSED OFFERING OF COMMON STOCK

14 Feb 2018

BRIEF-Avid Bioservices, Oncologie Enter Into Asset Assignment, Purchase Agreement For Avid's PS-Targeting Program Including Bavituximab

* AVID BIOSERVICES AND ONCOLOGIE ENTER INTO ASSET ASSIGNMENT AND PURCHASE AGREEMENT FOR AVID’S PS-TARGETING PROGRAM INCLUDING BAVITUXIMAB

12 Feb 2018

Competitors

  Price Chg
DAIICHI SANKYO COMPANY, LIMITED (4568.T) ¥3,739 +11.00
HANALL BIOPHARMA (009420.KS) ₩31,300.00 +1,350.00
Pfizer Inc. (PFE.N) $36.82 +0.14
Johnson & Johnson (JNJ.N) $127.15 +0.39
Novartis AG (NOVN.S) CHF75.68 +0.44
Merck & Co., Inc. (MRK.N) $59.89 +0.26
Roche Holding Ltd. (ROG.S) CHF217.00 -0.75
Roche Holding Ltd. (RO.S) CHF222.00 -0.60
Bayer AG (BAYGn.DE) €97.15 -0.32
Bayer AG (BAYE.F) -- --

Earnings vs. Estimates